74 results on '"Zeuzem S"'
Search Results
2. Letter: impact of HBV genotypes and PC/BCP mutations on serum HBsAg levels in Chinese HBeAg negative patients-Authors′ reply
3. Editorial: HBsAg serum levels in HBeAg-negative chronic HBV infection-is it a matter of genotype? Authors’ reply
4. Impact of HBV genotype and mutations on HBV DNA and qHBsAg levels in patients with HBeAg-negative chronic HBV infection
5. Treatment of refractory ascites with an automated low-flow ascites pump in patients with cirrhosis
6. No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct-acting antivirals for hepatitis C in a large real-world cohort
7. The efficacy and safety of direct acting antiviral treatment and clinical significance of drug-drug interactions in elderly patients with chronic hepatitis C virus infection
8. Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy
9. The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis
10. The macrophage activation marker CD163 is associated with IL28B genotype and hepatic inflammation in chronic hepatitis C virus infected patients
11. Peginterferon add‐on results in more HBsAg decline compared to monotherapy in HBeAg‐positive chronic hepatitis B patients
12. Letter: proton pump inhibitor treatment and increased mortality in cirrhotic patients – authors' reply
13. Letter: proton pump inhibitors - severity of liver disease and mortality in patients with cirrhosis - authors' reply
14. Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis
15. Simeprevir with peginterferon/ribavirin for treatment of chronic hepatitis C virus genotype 1 infection: pooled safety analysis from Phase IIb and III studies
16. Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus
17. Polymorphisms ofHLA-DPare associated with response to peginterferon in Caucasian patients with chronic hepatitis B
18. The impact of antihyperlipidemic drugs on the viral load of patients with chronic hepatitis C infection: a meta-analysis
19. Commentary: vitamin D deficiency and liver cancer – cause, effect or myth? Authors’ reply
20. Severe 25-hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma - a prospective cohort study
21. The new paradigm of hepatitis C therapy: integration of oral therapies into best practices
22. The number needed to treat to prevent mortality and cirrhosis‐related complications among patients with cirrhosis and HCV genotype 1 infection
23. Impact of ribavirin priming on viral kinetics and treatment response in chronic hepatitis C genotype 1 infection
24. Serum microRNA-122 kinetics in patients with chronic hepatitis C virus infection during antiviral therapy
25. Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin
26. Dynamics of hepatitis B virus quasispecies heterogeneity and virologic response in patients receiving low‐to‐moderate genetic barrier nucleoside analogs
27. Acoustic radiation force impulse imaging for non‐invasive assessment of liver fibrosis in chronic hepatitis B
28. Optimized threshold for serum HCV RNA to predict treatment outcomes in hepatitis C patients receiving peginterferon alfa‐2a/ribavirin
29. Modulation of replication efficacy of the hepatitis C virus replicon Con1 by site-directed mutagenesis of an NS4B aminoterminal basic leucine zipper
30. MUTYH hotspot mutations in unselected colonoscopy patients
31. New developments in HCV therapy
32. MUTYHhotspot mutations in unselected colonoscopy patients
33. Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta‐analysis
34. Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection
35. Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa-2b
36. Comparison of Envelope 2 CD81 binding regions in PBMC-derived versus serum-derived hepatitis C virus isolates: higher conservation of CD81 region 2 in PBMC isolates
37. The complex interrelationships between chronic lung and liver disease: a review
38. Review article: specifically targeted anti-viral therapy for hepatitis C - a new era in therapy
39. Effect of ribavirin on the frequency of RNase L cleavage sites within the hepatitis C viral genome
40. Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C
41. Absence of the interstitial cell of Cajal network in mitochondrial neurogastrointestinal encephalomyopathy
42. An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpectII) during albinterferon alfa-2b combination therapy for chronic hepatitis C
43. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C
44. Expert opinion on the treatment of patients with chronic hepatitis C
45. Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon α and ribavirin therapy
46. Meta-analysis: the outcome of anti-viral therapy in HCV genotype 2 and genotype 3 infected patients with chronic hepatitis
47. Clinical trial: individualized treatment duration for hepatitis C virus genotype 1 with peginterferon-alpha 2a plus ribavirin
48. Somatic hypermutation and mRNA expression levels of the BCL‐6 gene in patients with hepatitis C virus‐associated lymphoproliferative diseases*
49. Impaired health-related quality of life in patients with chronic hepatitis C and persistently normal aminotransferase levels
50. Review article: management of patients with chronic hepatitis C virus infection and 'normal' alanine aminotransferase activity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.